Ashot S. Harutyunyan

Citado por

	Total	Desde 2019
Citas	7975	3880
Índice h	30	26
Índice i10	38	32

880

440

220

660

200920102011201220132014201520162017201820192020202120222023202429 61 161 231 265 543 763 707 674 542 507 696 867 800 766 240

Acceso público

Ver todo

30 artículos

3 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Robert KralovicsPrincipal Investigator, Medical University of ViennaDirección de correo verificada de meduniwien.ac.at
Mario CazzolaProfessor of Hematology, University of PaviaDirección de correo verificada de unipv.it
Roland JägerDepartment of Laboratory Medicine, Medical University of ViennaDirección de correo verificada de meduniwien.ac.at
Jelena Milosevic FeenstraThermo Fisher ScientificDirección de correo verificada de thermofisher.com
Nada JabadoMcGill Univ.Dirección de correo verificada de mcgill.ca
Passamonti FrancescoUniversity of Insubria, Varese, ItalyDirección de correo verificada de uninsubria.it
Levon YepiskoposyanInstitute of Molecular Biology, NAS, ArmeniaDirección de correo verificada de mb.sci.am
Hamid NikbakhtAssociate Director, Advanced Analytics, Oncology EMU, GlaxoSmithKline (GSK)Dirección de correo verificada de gsk.com
Jacek MajewskiProfessor of Human Genetics, McGill UniversityDirección de correo verificada de mcgill.ca
Ben GarciaAssociate Professor, University of Pennsylvania School of MedicineDirección de correo verificada de mail.med.upenn.edu
Eric Bareke, PhDMcGill UniversityDirección de correo verificada de mcgill.ca
Haifen ChenMcGill UniversityDirección de correo verificada de mail.mcgill.ca
Dylan M MarchioneSenior Scientist, Servier PharmaceuticalsDirección de correo verificada de servier.com
Chao LuColumbia UniversityDirección de correo verificada de cumc.columbia.edu
Vannucchi AMProfessor of Hematology, University of FlorenceDirección de correo verificada de unifi.it
Pabinger Ingrid or Pabinger-Faching I...Medical University Vienna, Division of Haematology and HaemostaseologyDirección de correo verificada de meduniwien.ac.at
Giovanni MartinelliProfessor of Hematology "L. e A. Seragnoli" InstituteDirección de correo verificada de unibo.it
Doris ChenMax Perutz Labs, University of Vienna, AustriaDirección de correo verificada de univie.ac.at
Stefan N. ConstantinescuProfesseur, Université catholique de Louvain- de Duve Institute, Member, Ludwig Institute for Cancer ResearchDirección de correo verificada de bru.licr.org
Giulio Superti-FurgaScientific Director, CeMM Research Center for Molecular Medicine of the Austrian Academy ofDirección de correo verificada de cemm.oeaw.ac.at

Seguir

Ashot S. Harutyunyan

Department of Human Genetics, McGill University

Dirección de correo verificada de mail.mcgill.ca

Cancer Genetics Brain Cancers Epigenomics Myeloproliferative Neoplasms Biostatistics


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Somatic mutations of calreticulin in myeloproliferative neoplasms T Klampfl, H Gisslinger, AS Harutyunyan, H Nivarthi, E Rumi, JD Milosevic, ... New England Journal of Medicine 369 (25), 2379-2390, 2013	2351	2013
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease A Zimprich, A Benet-Pagès, W Struhal, E Graf, SH Eck, MN Offman, ... The American Journal of Human Genetics 89 (1), 168-175, 2011	1059	2011
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes E Rumi, D Pietra, V Ferretti, T Klampfl, AS Harutyunyan, JD Milosevic, ... Blood 123 (10), 1544-1551, 2014	746	2014
A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms D Olcaydu, A Harutyunyan, R Jäger, T Berg, B Gisslinger, I Pabinger, ... Nature genetics 41 (4), 450-454, 2009	431	2009
The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape DN Weinberg, S Papillon-Cavanagh, H Chen, Y Yue, X Chen, ... Nature 573 (7773), 281-286, 2019	394	2019
H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis AS Harutyunyan, B Krug, H Chen, S Papillon-Cavanagh, M Zeinieh, ... Nature communications 10 (1), 1262, 2019	261	2019
p53 lesions in leukemic transformation A Harutyunyan, T Klampfl, M Cazzola, R Kralovics New England Journal of Medicine 364 (5), 488-490, 2011	251	2011
H3. 3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas M Pathania, N De Jay, N Maestro, AS Harutyunyan, J Nitarska, ... Cancer cell 32 (5), 684-700. e9, 2017	229	2017
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression T Klampfl, A Harutyunyan, T Berg, B Gisslinger, M Schalling, K Bagienski, ... Blood 118 (1), 167-176, 2011	207	2011
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms W Tapper, AV Jones, R Kralovics, AS Harutyunyan, K Zoi, W Leung, ... Nature Communications 6, 2015	184	2015
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms R Jäger, H Gisslinger, F Passamonti, E Rumi, T Berg, B Gisslinger, ... Leukemia 24 (7), 1290-1298, 2010	180	2010
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas B Krug, N De Jay, AS Harutyunyan, S Deshmukh, DM Marchione, ... Cancer cell 35 (5), 782-797. e8, 2019	175	2019
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies A Puda, JD Milosevic, T Berg, T Klampfl, AS Harutyunyan, B Gisslinger, ... American journal of hematology 87 (3), 245-250, 2012	126	2012
Histone H3. 3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis CCL Chen, S Deshmukh, S Jessa, D Hadjadj, V Lisi, AF Andrade, D Faury, ... Cell 183 (6), 1617-1633. e22, 2020	112	2020
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis E Rumi, AS Harutyunyan, D Pietra, JD Milosevic, IC Casetti, M Bellini, ... Blood 123 (15), 2416-2419, 2014	103	2014
Clinical significance of genetic aberrations in secondary acute myeloid leukemia JD Milosevic, A Puda, L Malcovati, T Berg, M Hofbauer, A Stukalov, ... American journal of hematology 87 (11), 1010-1016, 2012	100	2012
Population genetics of familial Mediterranean fever: a review L Yepiskoposyan, A Harutyunyan European Journal of Human Genetics 15 (9), 911-916, 2007	97	2007
H3 K27M and EZHIP impede H3K27-methylation spreading by inhibiting allosterically stimulated PRC2 SU Jain, AQ Rashoff, SD Krabbenhoft, D Hoelper, TJ Do, TJ Gibson, ... Molecular cell 80 (4), 726-735. e7, 2020	96	2020
Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors C Marty, C Saint-Martin, C Pecquet, S Grosjean, J Saliba, C Mouton, ... Blood 123 (9), 1372-1383, 2014	91	2014
The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms D Olcaydu, E Rumi, A Harutyunyan, F Passamonti, D Pietra, C Pascutto, ... Haematologica 96 (3), 367-374, 2011	83	2011

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores